FACTION BRIEF

The Perceptual Standards Board

Self-regulatory body for neural advertising — 99.9% approval rate (847 approved, 1 rejected)

TypeSelf-regulatory body for neural advertisingEstablished2171OperatorFunded by the advertising industry it regulatesMembers3 advertising industry reps, 2 Nexus executives, 1 Helix neuroscientist, 1 'public interest advocate' (selected by Good Fortune)

Overview

The Perceptual Standards Board is the regulatory body that oversees neural advertising in the Sprawl. It is funded by the advertising industry it regulates. It has rejected one advertising technique in fifteen years.

That technique — Guardian's amygdala stimulation protocol, 2178 — caused sustained insomnia in 34% of exposed subjects. The insomnia reduced quarterly productivity outputs by an estimated 11.2% across affected sectors. The Board's rejection filing runs nine pages. The word "insomnia" appears fourteen times. The word "manipulation" appears zero times.

The Board was established in 2171 by Nexus Dynamics as a preemptive measure to forestall regulation of neural advertising under Zephyria's emerging Consciousness Rights framework. The logic was efficient: an industry that regulates itself cannot be regulated by others. The seven members include three advertising industry representatives, two Nexus executives, one Helix neuroscientist, and one "public interest advocate" selected from a short list maintained by Good Fortune's public affairs division.

The Board reviews proposed techniques for "perceptual safety" — ensuring advertising does not produce adverse neurological effects, does not impair cognitive function, and does not exceed "reasonable" influence thresholds. It has approved 847 techniques. Its definitions of "adverse," "impair," and "reasonable" have been revised forty-one times since 2171, always in the direction of greater permissiveness, always unanimously.

The Productivity Standard

The Board does not regulate manipulation. The Board regulates whether manipulation makes workers miss shifts.

This is not subtext. It is the recorded operational logic of every filing the Board has produced since 2171. The seven members do not ask "does this technique influence the user?" All neural advertising influences by design. They ask "does this influence reduce the user's value as an economic unit?" The answer determines everything.

In 2179, the Board approved CLP-mediated craving induction for Wholesome branded nutrition — a technique that generates measurable hunger responses in subjects who have already eaten. The technique causes documented caloric overconsumption in 67% of exposed users. Approval was unanimous. The filing notes that "appetite stimulation within non-pathological ranges does not constitute cognitive impairment." The users eat more. Wholesome sells more. Nobody misses work.

The same year, the Board reviewed a technique for ambient anxiety elevation designed to increase urgency in Good Fortune loan applications. The technique worked. Approval rate among exposed populations rose 23%. It also produced a 4% spike in absenteeism — subjects reported feeling "generally unwell" on mornings following exposure. The technique was sent back for revision. Not rejected. Revised. The resubmitted version achieved the same anxiety response with a 0.7% absenteeism rate. Approved unanimously. The loan application spike held at 19%.

The pattern is consistent across all 847 approvals. Craving induction, aspiration modeling, social comparison amplification, purchase urgency, brand loyalty reinforcement — each technique reshapes cognition toward a commercial outcome. Each was approved provided the reshaping did not impair the subject's capacity to show up for work the next morning. A technique that makes you want things you don't need is perceptually safe. A technique that makes you too anxious to leave your apartment is a productivity risk. The Three megacorporations that fund the Board's operations have never disagreed on this distinction.

Guardian's amygdala stimulation remains the sole rejection because Guardian failed to solve the productivity problem before resubmitting. The manipulation was fine. The sick days were not.

Case File — Additional Record
Approval Rate	99.9% — 847 techniques approved, 1 rejected
Sole Rejection	Guardian amygdala stimulation (2178) — rejected because it reduced productivity, not because it was manipulative
Scope	Regulates neural advertising ONLY — does not regulate Attention Tithe, Calibration, Smoothing, or other value injection forms
Purpose Stated	Ensure 'perceptual safety' in neural advertising
Purpose Actual	Provide legal and rhetorical cover for the advertising industry

The Approval Pipeline

The 99.9% approval rate is not corruption. It is selection bias.

Nexus maintains a pre-submission consultation service — technically independent from the Board, housed in the same building, staffed by two former Board members — where advertising firms can test their techniques against likely Board criteria before formal review. Techniques that would fail are identified early and either modified or shelved. The consultation service charges 12,000 credits per review. It has processed approximately 3,200 techniques since 2175. Roughly 2,350 were withdrawn or modified before reaching the Board.

The techniques that reach the seven members on the 52nd floor of Nexus Central have already been pre-filtered for approval. The quarterly meetings last, on average, forty-seven minutes. The proceedings are recorded on infrastructure maintained by Nexus's data division — the same servers that process the CLP-mediated advertising the Board is reviewing. The recordings are classified. No one has requested access.

Jurisdictional Architecture

The Board regulates neural advertising. It does not regulate the Attention Tithe. It does not regulate the Calibration. It does not regulate the Smoothing. It does not regulate any form of value injection not explicitly classified as "advertising."

The distinction between "advertising" (regulated, Board-approved, legally shielded) and "value injection" (unregulated, uncategorized, functionally identical) is maintained by the same corporations that profit from maintaining it. The Value Injection ecosystem operates in the space the Board was designed to leave empty. The Attention Abolitionists have filed seven formal challenges to the Board's jurisdictional boundaries since 2177. Each challenge was reviewed by the Board itself. Each was denied.

In Zephyria, the Board has no jurisdiction, and the Consciousness Rights Act applies standards the Board would not survive. In the Deep Dregs, the Board is unknown — residents who bear the densest neural advertising exposure in the Sprawl have never heard of the body that approved the techniques reshaping their cognition.

Does not regulate the Attention Tithe, Calibration, Smoothing, or any non-advertising value injection form

Sensory Details

The Board meets quarterly in a conference room on the 52nd floor of Nexus Central's regulatory wing. Temperature-controlled at 22°C — the standard Nexus comfort setting, identical to the ambient temperature in Nexus's sensory advertising development suites. The lighting is calibrated for cognitive clarity at 5,200 Kelvin. The seven members sit at a curved table facing a holographic display of the technique under review. The Helix neuroscientist sits at the far left of the curve, where the display resolution drops 12% due to viewing angle. She has requested a seat change twice. The requests were tabled.

Visual Identity

Color palette: Corporate blue (#0066CC) with regulatory gold (#FFD700) trim
Key symbol: A rubber stamp — the Board's most honest visual
Lighting: Institutional blue-white at 5,200K — the cold clarity of a process designed to produce approval, not discomfort

Archive annex — 4 earlier filings on this recordClose the archive annex

Recovered Historical Material

The Attention Abolitionists

Diplomatic Posture

The Perceptual Standards Board is the regulatory body that oversees neural advertising in the Sprawl. It is funded by the advertising industry it regulates. It has rejected one technique in fifteen years.

The Jurisdictional Line

Field Report: Quarterly Review Session

Observation notes, 52nd floor, Nexus Central regulatory wing.

Regulatory Capture as Architecture

Board Composition

Advertising Representatives (3)

Nexus Executives (2)

Helix Neuroscientist (1)

Public Interest Advocate (1)

The Guardian Rejection (2178)

Good Fortune selects the "public interest advocate" — the Board's only non-industry voice, chosen by an industry voice. The arrangement is circular. The circle is deliberate.

Attention Tithe, the Calibration, the Smoothing → /world/systems/the-value-injection

Neural Advertising Architecture → /world/technology/neural-advertising-architecture

Nexus Dynamics established the Board in 2171 as a preemptive measure. Zephyria was developing a Consciousness Rights framework. The Board arrived first. Seven members: three advertising industry representatives, two Nexus executives, one Helix neuroscientist, and one "public interest advocate" selected from a short list maintained by Good Fortune's public affairs division.

The Board reviews proposed techniques for "perceptual safety" — ensuring advertising does not produce adverse neurological effects, does not impair cognitive function, and does not exceed "reasonable" influence thresholds. Its definitions of "adverse," "impair," and "reasonable" have been revised forty-one times since 2171, always in the direction of greater permissiveness, always unanimously.

Neural advertising techniques that carry Board approval are shielded from regulatory challenge in corporate territories. The stamp is the product. Eight hundred and forty-seven techniques carry the stamp. The industry opted into a regulatory body that would legitimate what it was already doing. Workers in Board-approved advertising zones have no avenue to contest the techniques reshaping their cognition — the only body with jurisdiction has already reviewed and approved each one.

The Board does not regulate manipulation. It regulates whether manipulation makes workers miss shifts.

The Board's threshold for rejection is not "does this influence the user?" — all neural advertising influences by design. The threshold is "does this influence reduce the user's value as an economic unit?" In 2178, Guardian's amygdala stimulation technique caused insomnia in 34% of exposed subjects. The productivity loss was 11.2% across affected sectors. The rejection memo uses the word "insomnia" fourteen times. It does not use the word "manipulation." The manipulation was acceptable. The lost hours were not.

Nexus maintains a pre-submission consultation service — technically independent from the Board, housed in the same building, staffed by two former Board members — where advertising firms test techniques against likely Board criteria before formal review. Techniques that would fail are identified early. Of approximately 3,200 techniques processed since 2175, roughly 2,350 were withdrawn or modified before reaching the seven members on the 52nd floor. The 99.9% approval rate is not corruption. It is selection bias. Only techniques likely to pass are submitted.

The Board regulates neural advertising. It does not regulate the Attention Tithe, the Calibration, the Smoothing, or any form of value injection not classified as "advertising." The distinction between "advertising" and "not advertising" is maintained by the same corporations that benefit from maintaining it. The Attention Abolitionists have filed seven formal challenges to the Board's jurisdictional boundaries since 2177. Each was reviewed by the Board itself. Each was denied.

Temperature-controlled at 22°C — the standard Nexus comfort setting, identical to the ambient temperature in Nexus's sensory advertising development suites. Lighting calibrated for cognitive clarity at 5,200 Kelvin. Seven members at a curved table facing a holographic display. The Helix neuroscientist sits at the far left of the curve, where display resolution drops 12% due to viewing angle. She has requested a seat change twice. Both requests were tabled.

Quarterly meetings average forty-seven minutes. Each technique receives between four and twelve minutes. The neuroscientist asks technical questions. The public interest advocate asks questions that sound substantive. The advertising representatives nod. The Nexus executives watch the clock. The proceedings are recorded on infrastructure maintained by Nexus's data division — the same servers that process the CLP-mediated advertising under review. The recordings are classified.

A rubber stamp sits on the table. Approvals are digital. Someone placed it there years ago and no one has removed it. It may be the Board's most honest artifact: a symbol of a process whose conclusion precedes its procedure.

Three seats held by executives from the Sprawl's largest neural advertising firms. They rotate annually from a pool of eight firms that collectively control 91% of the neural advertising market. The rotation creates the appearance of diversity within a closed system.

Nexus created the Board. Nexus funds the Board. Nexus holds two of seven seats and maintains the servers that record the proceedings. The relationship is not influence — it is ownership wearing the language of governance.

One seat for a Helix BioTech neuroscientist. The technical questions are genuine. The authority to act on the answers is not. The neuroscientist provides the language of rigor. The Board provides the outcome of accommodation. She sits at the angle where the display resolution drops 12%.

One seat for the public. The advocate is selected from a short list maintained by Good Fortune's public affairs division. The public does not compile the list. The public does not select from it. The seat is labeled "public interest." The interest it represents is labeled elsewhere.

The Board was not captured by industry after its creation. It was created by industry to prevent capture by government. The usual narrative — a well-intentioned regulator gradually corrupted — does not apply. There was no gradual corruption. The Board's purpose has been consistent since 2171: provide the stamp.

The Zephyrian Compromise

Internal Nexus communications from 2170 confirm the Board was designed to preempt Zephyria's proposed Neural Advertising Standards Act — independent oversight with enforcement authority. The Board offered voluntary self-regulation with no enforcement mechanism. Zephyria adopted a compromise: recognize the Board as the primary regulatory body while reserving the right to intervene. The intervention clause has never been invoked. The Board cost Nexus approximately ¢4 million. The Standards Act would have imposed estimated compliance costs of ¢800 million annually across the industry.

The Deep Dregs Problem

In Zephyria, the Board has no jurisdiction and the Consciousness Rights Act applies standards the Board would not survive. In the Deep Dregs, the Board is unknown. Residents bearing the densest neural advertising exposure in the Sprawl have never heard of the body that approved the techniques reshaping their cognition. The Board regulates the most visible advertising market. The most vulnerable exposure zones were never part of the conversation.

The sole rejection: Guardian's amygdala stimulation protocol. The technique amplified fear responses to drive security product purchases. It caused insomnia in 34% of subjects and reduced average productive hours by 1.7 per day across exposed populations. The rejection memo runs nine pages. "Insomnia" appears fourteen times. "Manipulation" appears zero times.

The technique was resubmitted after revision. The revised version achieved the same anxiety response with a 0.7% absenteeism rate. It was approved unanimously. Guardian's original filing was not rejected because it manipulated consumers. It was rejected because it made them tired.

The 2179 Craving Induction Approval

The Board approved CLP-mediated craving induction for Wholesome branded nutrition — a technique generating measurable hunger responses in subjects who have already eaten. The technique causes documented caloric overconsumption in 67% of exposed users. The approval filing notes that "appetite stimulation within non-pathological ranges does not constitute cognitive impairment."

That same year, the Board reviewed a technique for ambient anxiety elevation to increase urgency in Good Fortune loan applications. It worked. It also produced a 4% spike in absenteeism. The technique was sent back for revision — not rejected, revised — until absenteeism dropped to 0.7%. The loan application spike held at 19%. The craving induction technique made people eat more. Nobody missed work.

Nexus created the Board as a ¢4 million preemptive measure against ¢800 million in annual compliance costs. Two of seven seats. Hosts the quarterly meetings. Maintains the classified proceedings on its own servers.

Every CLP-mediated technique operating in corporate territories carries a Board approval stamp. The architecture operates within a regulatory framework designed to approve it.

The Board regulates advertising. Value injection is not advertising. The most invasive cognitive influence systems in the Sprawl operate in the space the Board was designed to leave empty.

Seven formal challenges to the Board's jurisdictional boundaries filed since 2177. Seven reviewed by the Board itself. Seven denied. The Board does not otherwise respond to the Abolitionists. Responding would acknowledge a critique the Board's existence is designed to make unnecessary.